LEP and breast cancer: In addition, it has been shown how leptin signaling may potentiate ERα’s role in a lysine to arginine mutation at residue 303 (K303R) within the hinge domain of ERα, which promotes the growth and progression of breast cancer, especially in K303R-associated breast cancer [169].